Geneva Capital Management LLC raised its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 11.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,745,828 shares of the business services provider's stock after purchasing an additional 176,152 shares during the quarter. Exponent comprises 2.6% of Geneva Capital Management LLC's portfolio, making the stock its 8th largest holding. Geneva Capital Management LLC owned about 3.44% of Exponent worth $141,517,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. lifted its position in shares of Exponent by 2.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 441,646 shares of the business services provider's stock valued at $35,800,000 after acquiring an additional 8,501 shares during the last quarter. Bessemer Group Inc. grew its position in shares of Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after purchasing an additional 346 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Exponent in the first quarter valued at about $665,000. Fifth Third Bancorp grew its position in shares of Exponent by 14.4% in the first quarter. Fifth Third Bancorp now owns 6,835 shares of the business services provider's stock valued at $554,000 after purchasing an additional 858 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its position in shares of Exponent by 29.9% in the first quarter. Farther Finance Advisors LLC now owns 3,274 shares of the business services provider's stock valued at $265,000 after purchasing an additional 753 shares during the last quarter. 92.37% of the stock is owned by institutional investors.
Exponent Price Performance
Shares of NASDAQ EXPO traded down $0.33 during mid-day trading on Friday, hitting $70.94. The company had a trading volume of 91,184 shares, compared to its average volume of 310,028. The business's 50-day simple moving average is $74.27 and its 200-day simple moving average is $79.74. Exponent, Inc. has a 12 month low of $63.81 and a 12 month high of $115.75. The firm has a market cap of $3.60 billion, a P/E ratio of 35.50 and a beta of 0.89.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business had revenue of $132.87 million during the quarter, compared to analysts' expectations of $130.82 million. During the same quarter last year, the company earned $0.57 earnings per share. The firm's revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, September 5th. Exponent's dividend payout ratio (DPR) is presently 60.00%.
Insider Activity at Exponent
In related news, VP John Pye sold 2,000 shares of the stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the completion of the sale, the vice president owned 29,204 shares in the company, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Bradley A. James sold 2,694 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,267 shares of company stock worth $489,120. Company insiders own 1.60% of the company's stock.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.